BRAF V600E MUTATION

Clinical trials for BRAF V600E MUTATION explained in plain language.

Never miss a new study

Get alerted when new BRAF V600E MUTATION trials appear

Sign up with your email to follow new studies for BRAF V600E MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists hunt for brain tumor clues in blood and spinal fluid

Knowledge-focused Recruiting now

This study aims to find out if tiny pieces of tumor DNA (ctDNA) found in blood and spinal fluid can be used to monitor how a brain tumor responds to an experimental drug called plixorafenib. It will enroll 15 adults with a specific BRAF-V600E mutated brain tumor that has returned…

Matched conditions: BRAF V600E MUTATION

Phase: EARLY_PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:42 UTC

BRAF V600E MUTATION

Get alerted when new BRAF V600E MUTATION trials appear

Scientists hunt for brain tumor clues in blood and spinal fluid